NovoCure NVCR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 12.93 | -0.22 | -40,393 | -24 | ||
| 2025Q3 | 12.92 | -0.33 | -36,021 | -37 | ||
| 2025Q2 | 17.80 | -0.36 | -39,521 | -40 | ||
| 2025Q1 | 17.82 | -0.31 | -37,865 | -34 | ||
| 2024Q4 | 29.80 | -0.61 | -63,304 | -66 | ||
| 2024Q3 | 15.63 | -0.28 | -32,092 | -31 | ||
| 2024Q2 | 17.13 | -0.31 | -33,580 | -33 | ||
| 2024Q1 | 15.63 | -0.36 | -41,520 | -39 | ||
| 2023Q4 | 14.93 | -0.44 | -51,716 | -47 | ||
| 2023Q3 | 16.15 | -0.47 | -58,245 | -49 | ||
| 2023Q2 | 41.50 | -0.54 | -62,660 | -57 | ||
| 2023Q1 | 60.14 | -0.50 | -60,249 | -53 | ||
| 2022Q4 | 73.35 | -0.35 | -42,978 | -37 | ||
| 2022Q3 | 75.98 | -0.26 | -24,611 | -27 | ||
| 2022Q2 | 69.50 | -0.23 | -21,128 | -24 | ||
| 2022Q1 | 82.85 | -0.04 | -806 | -5 | ||
| 2021Q4 | 75.08 | -0.25 | -23,398 | -26 | ||
| 2021Q3 | 116.17 | 1026.67 | -0.13 | -8,552 | -13 | |
| 2021Q2 | 221.82 | 1955.93 | -0.14 | -12,295 | -15 | |
| 2021Q1 | 132.18 | 683.40 | -0.04 | -88 | -4 |